Safety of food at airports spotty
USA Today - 1 hour 18 minutes agoAirport restaurants packed with holiday travelers have been cited in the past year for hundreds of food safety violations, local health department reports show.
4390 Stories, most recent news story added 41 minutes ago
Airport restaurants packed with holiday travelers have been cited in the past year for hundreds of food safety violations, local health department reports show.
Should people who don't have high cholesterol take a cholesterol-lowering statin? Maybe, according to the U.S. Food and Drug Administration, which is considering an advisory panel's recent recommendation to do just that.
There is no safety problem with the vaccine, which are being recalled for lack of potency, and people who received doses from the affected lots do not need to be revaccinated, officials said.
Drugmaker MedImmune is recalling nearly 5 million doses of swine flu vaccine because the nasal spray appears to lose strength over time, federal health officials announced Tuesday.
Swiss food giant Nestle made misleading claims about the health benefits of some children's beverages, U.S. regulators said in letters released on Tuesday.
Federal regulators under President Barack Obama have sharply shifted course on long-standing policy toward pharmaceutical residues in the nation's drinking water, taking a critical first step toward regulating some of the contaminants while acknowledging they could threaten human health.
There's no evidence Merck & Co.'s blockbuster cholesterol drug Vytorin causes cancer, federal regulators said Tuesday. They reviewed reams of data after a patient study last year raised suspicions of a link, weakening sales already hurt by questions about the drug's efficacy.
Consumers are inundated with health advice from a host of sources: movie stars, TV docs and even the Internet.
CAMBRIDGE, Massachusetts, December 22 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that it has submitted a BLA with the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease.
Dec. 22 (Bloomberg) -- AstraZeneca Plc’s MedImmune unit announced a recall of 4.7 million doses of its nasal spray version of the swine flu vaccine because tests showed a decline in potency, U.S. regulators said.
British drugmaker Shire PLC said Tuesday it filed for U.S. marketing approval of its Fabry disease treatment Replagal. Replagal is available under Food and Drug Administration restrictions, and the company is seeking full approval.
Mayor Gavin Newsom plans to propose an ordinance that would require retailers to display radiation levels. Studies on the health risks are not conclusive, one environmental group acknowledges. San Francisco officials are debating whether to make this famously liberal city the first in the nation to require retailers to prominently post the amount of radiation emitted by cellphones.
Dec. 22 (Bloomberg) -- Nestle SA’s Juicy Juice and Boost beverages for children violate U.S. rules about marketing health claims, regulators said. The Food and Drug Administration posted a warning letter on its Web site today ordering the Vevey, Switzerland-based company to remove claims about the brain development benefits and sugar content of its Juicy Juice product for infants because they ...
Nasal swine flu vaccine recalled over potency loss; Conservative Dem defects to the GOP; Iran president flouts U.S. deadline; Drug war hero's family slain after raid
Dec. 23 (Bloomberg) -- A neurosurgeon at Southern General Hospital in Glasgow, Scotland, plans to drill a hole in a patient’s skull, insert a needle and inject 2 million stem cells from ReNeuron Group Plc into his brain early next year.
CLU event to focus on auto industryTHOUSAND OAKS — Former CEOs of Ford Motor Co. and J.D. Power and Associates will discuss the American automobile industry at the California Lutheran University Corporate Leaders Breakfast on Jan. 21.Donald E. Petersen, former chairman of the board of Ford Motor Co. , and James D. Power III, the founder of J.D. Power and Associates , will share their insight ...